Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Molecular mechanisms of treg-mediated T cell suppression.

Schmidt A, Oberle N, Krammer PH.

Front Immunol. 2012 Mar 21;3:51. doi: 10.3389/fimmu.2012.00051. eCollection 2012.

2.

Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2+), NF-κB, and NFAT signaling in conventional T cells.

Schmidt A, Oberle N, Weiss EM, Vobis D, Frischbutter S, Baumgrass R, Falk CS, Haag M, Brügger B, Lin H, Mayr GW, Reichardt P, Gunzer M, Suri-Payer E, Krammer PH.

Sci Signal. 2011 Dec 20;4(204):ra90. doi: 10.1126/scisignal.2002179.

PMID:
22375050
3.

Foxp3-mediated suppression of CD95L expression confers resistance to activation-induced cell death in regulatory T cells.

Weiss EM, Schmidt A, Vobis D, Garbi N, Lahl K, Mayer CT, Sparwasser T, Ludwig A, Suri-Payer E, Oberle N, Krammer PH.

J Immunol. 2011 Aug 15;187(4):1684-91. doi: 10.4049/jimmunol.1002321. Epub 2011 Jul 11.

4.

Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.

Klein S, Kretz CC, Ruland V, Stumpf C, Haust M, Hartschuh W, Hartmann M, Enk A, Suri-Payer E, Oberle N, Krammer PH, Kuhn A.

Ann Rheum Dis. 2011 Aug;70(8):1475-81. doi: 10.1136/ard.2009.116525. Epub 2010 Nov 19.

PMID:
21097800
5.

FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome.

Heid JB, Schmidt A, Oberle N, Goerdt S, Krammer PH, Suri-Payer E, Klemke CD.

J Invest Dermatol. 2009 Dec;129(12):2875-85. doi: 10.1038/jid.2009.175. Epub 2009 Jul 23.

7.
8.

Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus.

Franz B, Fritzsching B, Riehl A, Oberle N, Klemke CD, Sykora J, Quick S, Stumpf C, Hartmann M, Enk A, Ruzicka T, Krammer PH, Suri-Payer E, Kuhn A.

Arthritis Rheum. 2007 Jun;56(6):1910-20.

9.

Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death.

Fritzsching B, Oberle N, Pauly E, Geffers R, Buer J, Poschl J, Krammer P, Linderkamp O, Suri-Payer E.

Blood. 2006 Nov 15;108(10):3371-8. Epub 2006 Jul 25.

10.

Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.

Klemke CD, Fritzsching B, Franz B, Kleinmann EV, Oberle N, Poenitz N, Sykora J, Banham AH, Roncador G, Kuhn A, Goerdt S, Krammer PH, Suri-Payer E.

Leukemia. 2006 Jun;20(6):1123-9.

PMID:
16557241
11.

In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death.

Fritzsching B, Oberle N, Eberhardt N, Quick S, Haas J, Wildemann B, Krammer PH, Suri-Payer E.

J Immunol. 2005 Jul 1;175(1):32-6.

Supplemental Content

Loading ...
Support Center